Sljedeći

Auto Play

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

2 Pogledi • 07/03/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play